Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Gross Margin (2024 - 2025)

Historic Gross Margin for Pyxis Oncology (PYXS) over the last 2 years, with Q2 2025 value amounting to 100.0%.

  • Pyxis Oncology's Gross Margin changed N/A to 100.0% in Q2 2025 from the same period last year, while for Sep 2025 it was 100.0%, marking a year-over-year change of. This contributed to the annual value of 97.06% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q2 2025, Pyxis Oncology's Gross Margin is 100.0%.
  • In the past 5 years, Pyxis Oncology's Gross Margin ranged from a high of 100.0% in Q2 2025 and a low of 97.06% during Q1 2024